← back to search

Michael T. Lynskey

SNV Netherlands Development Organisation ·
Area of research
Epidemiology · Pharmacology
Research interest
Research interests include Substance Abuse Treatment and Outcomes, Cannabis and Cannabinoid Research, Prenatal Substance Exposure Effects, and Child and Adolescent Psychosocial and Emotional Development.
h-index
111
citations
40,846
works
501
NIH funding
primary concept
email

Recent publications

The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies
Psychological Medicine 2024cited by 10position: middledoi
Multivariate genome-wide association meta-analysis of over 1 million subjects identifies loci underlying multiple substance use disorders
Nature Mental Health 2023cited by 223position: middledoi
Cannabis use in Adolescence and Risk of Psychosis: Are there Factors that Moderate this Relationship? A Systematic Review and Meta-Analysis
Substance Abuse 2021cited by 107position: lastdoi
Developing a real-world evidence base for prescribed cannabis in the United Kingdom: preliminary findings from Project Twenty21
Psychopharmacology 2021cited by 44position: middledoi
The Relationship Between Childhood Physical and Sexual Abuse and Adolescent Cannabis Use: A Systematic Review
Frontiers in Psychiatry 2021cited by 43position: middledoi
The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study
Translational Psychiatry 2021cited by 27position: middledoi
Changes in delta‐9‐tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta‐analysis
Addiction 2020cited by 318position: lastdoi
Assessing the public health impacts of legalizing recreational cannabis use: the US experience
World Psychiatry 2020cited by 287position: lastdoi
Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case–control study
Psychological Medicine 2020cited by 86position: middledoi
The Effects of Cannabis Use on the Development of Adolescents and Young Adults
Annual Review of Developmental Psychology 2020cited by 86position: lastdoi
Global systematic review and ecological analysis of HIV in people who inject drugs: National population sizes and factors associated with HIV prevalence
International Journal of Drug Policy 2020cited by 35position: middledoi
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
The Lancet Psychiatry 2019cited by 839position: middledoi
Public health implications of legalising the production and sale of cannabis for medicinal and recreational use
The Lancet 2019cited by 358position: middledoi
Mobile telephone‐delivered contingency management interventions promoting behaviour change in individuals with substance use disorders: a meta‐analysis
Addiction 2019cited by 76position: middledoi
Characterising heterogeneity in the use of different cannabis products: latent class analysis with 55 000 people who use cannabis and associations with severity of cannabis dependence
Psychological Medicine 2019cited by 46position: middledoi
A Global Meta-analysis of the Prevalence of HIV, Hepatitis C Virus, and Hepatitis B Virus Among People Who Inject Drugs—Do Gender-Based Differences Vary by Country-Level Indicators?
The Journal of Infectious Diseases 2019cited by 44position: middledoi
Associations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysis
The Lancet Global Health 2019cited by 33position: lastdoi
Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use
Schizophrenia Bulletin 2019cited by 25position: middledoi
Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders
Nature Neuroscience 2018cited by 708position: middledoi
Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs
Addiction 2018cited by 259position: middledoi
Increasing potency and price of cannabis in Europe, 2006–16
Addiction 2018cited by 134position: lastdoi
Changes in cannabis potency and first-time admissions to drug treatment: a 16-year study in the Netherlands
Psychological Medicine 2018cited by 117position: lastdoi
A new approach to formulating and appraising drug policy: A multi-criterion decision analysis applied to alcohol and cannabis regulation
International Journal of Drug Policy 2018cited by 64position: middledoi
Genetic Predisposition vs Individual-Specific Processes in the Association Between Psychotic-like Experiences and Cannabis Use
JAMA Psychiatry 2018cited by 52position: middledoi
Denise Kandel's classic work on the gateway sequence of drug acquisition
Addiction 2018cited by 33position: firstdoi
Trans-ancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders
bioRxiv (Cold Spring Harbor Laboratory) 2018cited by 19position: middledoi
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review
The Lancet Global Health 2017cited by 1,475position: middledoi
Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review
The Lancet Global Health 2017cited by 431position: middledoi
Polysubstance use and misuse or abuse of prescription opioid analgesics: a multi-level analysis of international data
Pain 2017cited by 94position: lastdoi
Major depressive disorder, suicidal thoughts and behaviours, and cannabis involvement in discordant twins: a retrospective cohort study
The Lancet Psychiatry 2017cited by 75position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Arpana Agrawal · University of Oslo16 papers (2012–2018)Louisa Degenhardt · UNSW Sydney11 papers (2015–2020)Andrew C. Heath · Stanford University9 papers (2012–2018)Kathleen K. Bucholz · Yale University8 papers (2012–2017)Janni Leung · The University of Queensland8 papers (2017–2020)Wayne Hall · Florida Polytechnic University8 papers (2016–2020)Samantha Colledge‐Frisby · UNSW Sydney6 papers (2017–2020) · 6 papers (2017–2020)Evan B. Cunningham · UNSW Sydney6 papers (2017–2020)Katherine I. Morley · RAND Europe6 papers (2015–2017)Peter Vickerman · At Bristol6 papers (2017–2020)Amy Peacock · UNSW Sydney6 papers (2017–2020)Jason Grebely · UNSW Sydney6 papers (2017–2020) · 6 papers (2013–2017)Richard P. Mattick · UNSW Sydney6 papers (2017–2020)Sarah Larney · Burnet Institute6 papers (2017–2020) · 6 papers (2017–2019)Matthew Hickman · University of Bristol6 papers (2017–2020)Pamela A. F. Madden · Washington University in St. Louis5 papers (2012–2017)Adam Trickey · Institute for Health Metrics and Evaluation5 papers (2017–2020)